Facility
Dr. Reddy's Laboratories Hyderabad API Facility (Oncology)
Dr. Reddy's Hyderabad API manufacturing complex; FDA-inspected facility producing irinotecan hydrochloride and other oncology APIs. Converts camptothecin starting material (sourced from China) to irinotecan via semi-synthetic route (camptothecin → 10-hydroxycamptothecin → irinotecan via controlled chemical transformation steps). The Hyderabad facility supplies irinotecan API for Dr. Reddy's own generic injectable finished dose manufacturing and for third-party generic pharmaceutical clients. Dr. Reddy's is among the top-3 generic irinotecan suppliers to the U.S. hospital formulary market. Source: https://www.drreddys.com/investors/annual-reports
1
Inputs produced
1
Goods downstream
0
Incidents on record
0
Stories
What's produced here
1 input from this facility
Tap an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.